[1] |
Desantis CE, Ma J, Goding AS, et al. Breast cancer statistics, 2017, racial disparity in mortality by state [J]. Ca Cancer J Clin, 2017, 67(6):439-448.
|
[2] |
Yang Z, Zheng R, Zhang S, et al. Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013[J]. Chin J Cancer Res,2017,29(5):385-394.
|
[3] |
Brenner RJ. Percutaneous removal of postbiopsy marking clip in the breast using stereotactic technique[J]. AJR Am J Roentgenol, 2001,176(2):417-419.
|
[4] |
Fisher B. Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer[J]. Cancer,1969,24(6):1286-1289.
|
[5] |
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med, 2002, 347(16):1227-1232.
|
[6] |
Barentsz MW, van den Bosch MA, Veldhuis WB, et al. Radioactive seed localization for non-palpable breast cancer[J]. Br J Surg,2013,100(5):582-588.
|
[7] |
Volders JH, Haloua MH, Krekel NM, et al. Current status of ultrasound-guided surgery in the treatment of breast cancer[J]. World J Clin Oncol,2016,7(1):44-53.
|
[8] |
Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18[J]. J Clin Oncol, 1997, 16(7):2483-2493.
|
[9] |
郑新宇.乳腺癌保乳手术切缘问题[J].中国实用外科杂志,2011,31(10):928-931.
|
[10] |
Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence[J]. J Clin Oncol,2000,18(8):1668-1675.
|
[11] |
Patel J, Jenkins S. A technique for marking oncological breast tissue specimens[J].Ann Med Surg (Lond), 2016,7:7-8.
|
[12] |
Gray RJ, Pockaj BA, Garvey E, et al. Intraoperative margin management in breast-conserving surgery: a systematic review of the literature[J]. Ann Surg Oncol, 2018,25(1):18-27.
|
[13] |
Rahusen FD, Taets van Amerongen AH, van Diest PJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins[J].J Surg Oncol,1999, 72(2):72-76.
|
[14] |
Reedijk M, Hodgson N, Gohla G, et al. A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy[J].Am J Surg, 2012, 204(3):263-268.
URL
|
[15] |
Nurko J, Mancino AT, Whitacre E, et al. Surgical benefits conveyed by biopsy site marking system using ultrasound localization[J]. Am J Surg, 2005, 190(4):618-622.
|
[16] |
Corsi F, Sorrentino L, Sartani A, et al. Localization of nonpalpable breast lesions with sonographically visible clip: optimizing tailored resection and clear margins[J]. Am J Surg,2015,209(6):950-958.
|
[17] |
Baltzer PA, Benndorf M, Dietzel M, et al. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study[J]. AJR Am J Roentgenol,2010,194(6):1658-1663.
|
[18] |
Mahoney MC, Newell MS. Breast intervention: how I do it[J]. Radiology, 2013, 268(1):12-24.
URL
|
[19] |
鲁伦博,孔德兴,谢叻,等. 磁共振成像引导下乳腺病灶定位与活组织检查[J/CD]. 中华乳腺病杂志(电子版), 2018, 12(2):110-112.
|
[20] |
Hong MJ, Cha JH, Kim HH, et al. Second-look ultrasonography for MRI-detected suspicious breast lesions in patients with breast cancer[J]. Ultrasonography,2015,34(2):125-132.
|
[21] |
Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis[J]. Radiology, 2014, 273(2):401-409.
URL
|
[22] |
Thomassin-Naggara I, Lalonde L, David J, et al. A plea for the biopsy marker: how, why and why not clipping after breast biopsy?[J]. Breast Cancer Res Treat, 2012,132(3):881-893.
|
[23] |
Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J]. Lancet,2014,384(9938):164-172.
URL
|
[24] |
Dash N,Chafin SH,Johnson RR.Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer[J]. Am J Roentgenol,1999,173(4):911-917.
|
[25] |
Oh JL, Nguyen G, Whitman GJ, et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy[J]. Cancer, 2007,110(11):2420-2427.
|
[26] |
Kumar A, Puri R, Gadgil PV, et al. Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla[J]. World J Surg,2012,36(7):1453-1459.
URL
|
[27] |
Fu JF,Chen HL,Yang J,et al.Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis[J].PLoS One,2014,9(9):e105316.
|
[28] |
Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):2694-2702.
|
[29] |
Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review[J]. JAMA Oncol,2017,3(4):549-555.
|
[30] |
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial[J]. JAMA,2013,310(14):1455-1461.
|
[31] |
Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)[J]. Ann Surg,2016,263(4):802-807.
|
[32] |
《乳腺癌新辅助化疗后的病理诊断专家共识》编写组. 乳腺癌新辅助化疗后的病理诊断专家共识[J]. 中华病理学杂志,2015, 44(4): 232-236.
|
[33] |
Barentsz MW, Verkooijen HM, Pijnappel RM, et al. Sentinel lymph node localization with contrast-enhanced ultrasound and an I-125 seed: An ideal prospective development study[J]. Int J Surg, 2015, 14:1-6.
|
[34] |
van Nijnatten TJA, Simons JM, Smidt ML, et al. A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed localization in the axilla with the sentinel node procedure (RISAS): a dutch prospective multicenter validation study[J]. Clin Breast Cancer,2017,17(5):399-402.
|
[35] |
Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis[J]. Radiology, 2001, 218(2):510-516.
|
[36] |
Esserman LE, Cura MA, Dacosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy[J]. Radiographics, 2004, 24(1):147-156.
|
[37] |
Rüland AM, Hagemann F, Reinisch M, et al. Using a new marker clip system in breast cancer: Tumark Vision® clip-feasibility testing in everyday clinical practice[J]. Breast Care (Basel),2018,13(2):116-120.
|
[38] |
Sakamoto N, Ogawa Y, Tsunoda Y, et al. Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients[J]. Breast Cancer, 2017, 24(4):585-592.
|
[39] |
Carmon M, Olsha O, Gekhtman D, et al. Detectability of hygroscopic clips used in breast cancer surgery[J]. J Ultrasound Med,2017,36(2):401-408.
|
[40] |
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J].中国癌症杂志,2017,27(9):695-760.
|